netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.04.01  Expand sub section  Corticosteroids
Betamethasone sodium phosphate 0.1% + Neomycin 0.5% drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Restricted to Ophthalmology
 
Betamethasone sodium phosphate 0.1% drops/ointment
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Approved for inflammation in anterior segment, post-op to reduce inflammation
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Dexamethasone + Framycetin + Gramicidin drops
(Sofradex)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Dexamethasone + Neomycin + Polymyxin B drops/ointment
(Maxitrol)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Dexamethasone 0.1% eye drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Inflammation in anterior segment, post-op to reduce inflammation
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Dexamethasone 0.1% eye drops - preservative free
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Inflammation in anterior segment, post-op to reduce inflammation (single-use drops & preservative-free bottles)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Dexamethasone eye drops 0.1% preservative-free (Moorfields)
 
Dexamethasone intravitreal implant
(Ozurdex)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines. 
    • To be prescribed by Consultant Ophthalmologists ONLY for the treatment of Macular Oedema Secondary to Retinal Vein Occlusion as per NICE guidance.
    • See links below
  • RFL:
    • Approved for macular oedema following RVO in line with NICE TA (Ophthalmologist use only) 
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Branch Retinal Vein Occlusion (BRVO) Pathway
Link  NCL JFC: Central Retinal Vein Occlusion (CRVO) Pathway
Link  NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion
Link  NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema
Link  NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis
Fluocinolone acetonide intravitreal implant
(Iluvien)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines. 
    • To be prescribed by Consultant Ophthalmologists ONLY for the treatment of Macular Oedema Secondary to Retinal Vein Occlusion as per NICE guidance.
    • See links below
  • RFL:
    • Approved for diabetic macular oedema in line with NICE TA (Ophthalmologist use only) 
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • For Diabetic macular oedema after an inadequate response to prior therapy (Nov 2013 TA301)
 
Link  NCL JFC: Diabetic Macular Oedema (DMO)
Link  NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy
Link  NICE TA590: Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis
Link  NICE TA613: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy
Fluorometholone 0.1% eye drops
(FML)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • For mild inflammation
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Hydrocortisone sodium phosphate 3.35 mg/ml drops
(Softacort)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Approved for mild non-infectious allergic or inflammatory ocular surface diseases (JFC September 2019)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • As above
 
Loteprednol 0.5% eye drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to steroid-responder patients requiring topical steroids (2nd line)
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
Prednisolone eye drops (various strengths)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated (0.5% and 1% available)
  • RFL:
    • No restriction stated (0.3% and 1% available)
  • RNOH:
    • No restriction stated (0.5% and 1% available)
  • UCLH:
  • WH:
    • No restriction stated (0.5% and 1% available as licensed products; 0.3% and 0.03% available as unlicensed specials)
 
Prednisolone eye drops (various strengths) - preservative free
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated (0.5%)
  • RFL:
    • No restriction stated (0.1% bottles, 0.3% bottles, 0.5% single-use)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated (0.5% available as licensed products; 0.1%, 0.3%, 0.03% 10mL bottles available as unlicensed specials)
 
Rimexolone 1% eye drops
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for hypertensive uveitis 
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
Triamcinolone acetonide 40mg/1mL injection
(Kenalog)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
AAAAAAAA

Provider notes

  • NMUH:
    • Use of Triamcinolone (Kenalog®) injection intravitreally is unlicensed
    • See link below
  • RFL:
    • Approved for
      • Uveitic Macular oedema
      • Diabetic macular oedema
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NCL JFC: Diabetic Macular Oedema (DMO)
 ....
 Non Formulary Items
Dexamethasone + Tobramycin eye drops
(Tobradex)
(Ophthalmic)

View adult BNF View SPC online View childrens BNF
Non Formulary
Prednisolone 0.5% + Neomycin 0.5%
(Predsol-N)

View adult BNF View SPC online View childrens BNF
Non Formulary
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Homecare
Homecare

Traffic Light Status Information

Status Description

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary